Acrinova AB Series B Cash Flow-to-Debt Ratio
Acrinova AB Series B cash flow-to-debt ratio. Acrinova AB Series B (ACRI-B) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2026, meaning its operating cash flow of Skr7.28 Million could theoretically repay 0% of its total liabilities (Skr457.03 Million) in one year. Check Acrinova AB Series B cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Acrinova AB Series B (2014–2025)
Cash flow-to-debt ratio of Acrinova AB Series B from 2014 to 2025. Historical debt coverage capacity for Acrinova AB Series B across 12 annual periods. Check ACRI-B cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Acrinova AB Series B Cash Flow-to-Debt Ratio by Year (2014–2025)
Acrinova AB Series B cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Acrinova AB Series B. For the full cash flow conversion analysis, see cash efficiency ratio of Acrinova AB Series B.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.72x | Skr337.73 Million | Skr471.06 Million | ▲ +1339.8% |
| 2024 | 0.05x | Skr61.06 Million | Skr1.23 Billion | ▼ -15.0% |
| 2023 | 0.06x | Skr71.23 Million | Skr1.22 Billion | ▲ +384.5% |
| 2022 | -0.02x | Skr-23.76 Million | Skr1.15 Billion | ▼ -124.6% |
| 2021 | 0.08x | Skr79.90 Million | Skr956.25 Million | ▲ +32.3% |
| 2020 | 0.06x | Skr33.98 Million | Skr538.24 Million | ▲ +146.8% |
| 2019 | 0.03x | Skr10.57 Million | Skr412.98 Million | ▼ -54.3% |
| 2018 | 0.06x | Skr15.26 Million | Skr272.41 Million | ▼ -48.4% |
| 2017 | 0.11x | Skr25.46 Million | Skr234.44 Million | ▲ +32.0% |
| 2016 | 0.08x | Skr16.52 Million | Skr200.88 Million | ▲ +106.3% |
| 2015 | -1.31x | Skr-17.03 Million | Skr12.97 Million | ▼ -369.5% |
| 2014 | 0.49x | Skr41.33 Million | Skr84.86 Million | — |